Arrowhead Pharmaceuticals Inc. (ARWR)

Arrowhead Pharmaceuticals Inc. (ARWR $18.76)
- $18.76 Cap: $2.52B
- View ARWR Profile
- View Questions on ARWR

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Eli Lilly and Company (LLY $788.79)
- $788.79 Fwd P/E: 64.26X Cap: $748.52B
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $65.89)
- $65.89 Fwd P/E: 18.91X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
Arrowhead Pharmaceuticals Inc. (ARWR $18.76)
- $18.76 Cap: $2.52B
- View ARWR Profile
- View Questions on ARWR
BridgeBio Pharma Inc. (BBIO $47.27)
- $47.27 Cap: $8.94B
- View BBIO Profile
- View Questions on BBIO

Q: BNN announced yesterday that TEMA whose funds are theme based has created a new ETF on the theme of weight loss. What is your opinion on the selection of the companies in this ETF. Can you provide the trading symbol for this ETF?

Thank you, Mike

Mike

Read Answer Asked by Michael on November 24, 2023

Arrowhead Pharmaceuticals Inc. (ARWR $18.76)
- $18.76 Cap: $2.52B
- View ARWR Profile
- View Questions on ARWR

Q: Hi, I would like to have some info about this company. Buy hold or sell? I own a good position in my portefolio. Than you

Read Answer Asked by Denis on December 22, 2021

Arrowhead Pharmaceuticals Inc. (ARWR $18.76)
- $18.76 Cap: $2.52B
- View ARWR Profile
- View Questions on ARWR

Q: I have been very fortunate to have my second 10-bagger with ARWR bought at $4 in 2017 (after some earlier losses). It has been running very well recently but is down to-day on the news that they are issuing 4m shares at $58, well below yesterdays close of $68.66. Why would they issue new shares so far below the recent market? Is there something here to worry about?
Thanks for your great service, Bob.

Read Answer Asked by Lynn on December 04, 2019